PRODUCT SPECIFICATION Strength / Dose: 50 mg/2 mL per vial Dosage Form: Solution for intravenous infusion after dilution Packing Type: Glass vial with rubber stopper & aluminium seal, packed in carton Treatment:
Used in the treatment of:
B-cell Chronic Lymphocytic Leukemia (CLL)
Non-Hodgkin’s Lymphoma (NHL)
Fludarabine phosphate is a purine analogue that inhibits DNA synthesis and induces apoptosis in malignant lymphocytes.
Prescription Type: Prescription only (Rx) Generic Name (Drug Name): Fludarabine Phosphate Brand: Flu-stim
PRODUCT SPECIFICATION
Strength / Dose: 200 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) in appropriate patient populations (as per local/regional approval)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Azacitidine
Brand: Azatend-O
PRODUCT SPECIFICATION
Strength / Dose: 25 mg per capsule
Dosage Form: Oral capsule
Packing Type: Capsules in blister or bottle, packed in carton
Treatment: Used in the treatment of certain haematologic malignancies (e.g., multiple myeloma) according to approved indication
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Lenalidomide
Brand: Laviat 25
PRODUCT SPECIFICATION
Strength / Dose: 5 mg per capsule
Dosage Form: Oral capsule
Packing Type: Capsules in blister or bottle, packed in carton
Treatment: Used in the treatment of specific haematologic malignancies (e.g., multiple myeloma, myelodysplastic syndromes) as per approved indication
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Lenalidomide
Brand: Laviat 5